NOVO NORDISK INC. lobbying for NOVO NORDISK INC.

Filing 1st Quarter - Report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Expenses

$1,290,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 3

ANSLEY RHYNE

Previously held: Legislative Assistant, Senator Marco Rubio
CHAD YELINSKI

Previously held: Deputy Chief of Staff, Senator Ted Budd
ROSALYN KUMAR New on this filing

Previously held: Deputy Chief of Staff, Rep. Debbie Wasserman Schultz; Tax Counsel, Senator Stabenow

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 11

Centers For Medicare and Medicaid Services (CMS)
Commerce, Dept of (DOC)
Council of Economic Advisers (CEA)
Health & Human Services, Dept of (HHS)
Homeland Security, Dept of (DHS)
HOUSE OF REPRESENTATIVES
Office of Management & Budget (OMB)
SENATE
State, Dept of (DOS)
Treasury, Dept of
White House Office

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 1

S 150
Affordable Prescriptions for Patients Act of 2023

Lobbying activity 6

Health Issues

Obesity, Treat and Reduce Obesity Act, Insulin Pricing/affordability, IRA implementation and drug pricing legislation, supply chain, 340B, Intellectual Property/patent protection, S. 150 - the Affordable Prescriptions for Patients Act, Protect 340B Act, PBM Reform Act, General Compounding

Budget/Appropriations

Labor-HHS Appropriations Bill, Military Construction, Treat and Reduce Obesity Act, General Compounding, FDA Agricultural Appropriations bill

Medicare/Medicaid

Obesity, Treat and Reduce Obesity Act, IRA implementation, General engagement around drug pricing

Copyright/Patent/Trademark

S. 150, Affordable Prescriptions for Patients Act, Patent Protection, General IP Issues, General Compounding

Taxation/Internal Revenue Code

International and corporate tax issues

Tariff (miscellaneous tariff bills)

Tariffs and trade policy